CSF2 and cancer: In the context of oncolytic vaccines and cytokines, a study using MB49 cancer cells expressing male tumor antigen HY was used to evaluate the efficacy of VV-overexpressing HY (VV-HY) and GM-CSF (VV-GM-CSF) to overcome tumor-associated immune tolerance.